Navigation Links
Transcept Pharmaceuticals Appoints Key Senior Executives
Date:7/2/2008

Terrence Moore named as Vice President, Marketing and Sales; Susan Koppy

named as Vice President, Corporate Development

PT. RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate Development. Both Mr. Moore and Ms. Koppy will report to President & Chief Executive Officer Glenn A. Oclassen. "We are pleased to welcome both Terry and Susan to the senior management team at Transcept," said Mr. Oclassen. "Terry's extensive neuroscience marketing and sales management experience will be a tremendous asset to Transcept as we prepare to commercialize our lead product candidate, Intermezzo(R). Susan is an experienced senior business development executive and she will be a key contributor to Transcept's future success by identifying and securing new product opportunities and developing new partner relationships."

Mr. Moore brings over twenty years of sales, marketing, and business development experience in the pharmaceutical industry to his new role at Transcept. He has demonstrated exceptional results as a senior member of management teams at Organon Biosciences (now Schering Plough), Wyeth, Johnson & Johnson, and Eli Lilly. His contributions include building multi-billion dollar brands such as Prozac(R), Zyprexa(R), Risperdal(R), and Effexor XR(R). Immediately prior to joining Transcept, Mr. Moore served as Vice President of the Neuroscience Therapeutic Area for Organon Biosciences and was responsible for the creation and building of the Neuroscience Business Unit. Before joining Organon Biosciences, Mr. Moore served as Vice President, U.S. Marketing, Effexor XR(R) as well as Vice President, Global Strategy Depression Portfolio for Wyeth Pharmaceuticals. Mr. Moore holds a BS in Pharmacy from the University of Florida, a BA in Chemistry from the University of
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCa...PHM ) today reported completion of patient enrollm...Cotara® in patients with relapsed glioblastom...ncer. Cotara is a targeted monoclonal antibody li...ial new treatment for GBM. Cotara specifically ta...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRN...ity study evaluating the preclinical (animal study...ich combines technology from Weill,Cornell Medical...ential to,treat inherited anemias such as Cooley,s...ries of technologies to expand, ex vivo,populatio...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- ...rkets are in turmoil and uncertainty is part of ma...e pharma industry has been,relatively immune to th...a,vacation. , During the midst of the dif...ohnson & Johnson inaugurated an R&D center...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Report...port is available in its catalogue: ,, Chromi...rtlinker.com/p0164494/Chromium---Global-Market-Tre...rimarily influenced by stainless steel, while grow... is also important for growth of chromium metal. E...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...er,therapeutics company, announced today that Timo...Chief Scientific Officer., "We are thrilled that ... A. Olson, President and CEO at Mersana. "His exte...rience with polymer-based drug systems are an,idea...impact he will have,on our newest programs, his co...
...America, Inc. (OTC Bulletin Board: CBAI), the umbi...http://www.cordblood-america.com ) focused on,brin...milies nationwide and,internationally, today annou... by the leading biotechnology publication in Greec...hip in 2006 named a.bourkas Co.,United., "Stem ce...
...,Inc. (eRT), (Nasdaq: ERES ), a leading provider ...on and interpretation services including,expert co...and services,(electronic data capture and electron... today that it will release its 2007 fourth quarte...n Tuesday, February 26,2008 after the market close...
Other Biology Technology:Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greece's Leading Biotech Magazine 2eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008 2
(Date:12/3/2009)...t dwellers must be included in the design of the u...d a humanitarian crisis, according to a scientist ... Nature , Dr Simon Lewis argues that at least 50% ...nhagen, known as REDD (Reducing Emissions from Def...est dwellers directly, and their property rights a...
(Date:12/3/2009)...0-year record low in Antarctic snowmelt that occur...ue to concurrent strong positive phases for two ma...ation) and SAM (Southern Hemisphere Annular Mode),...or of Earth & Atmospheric Sciences at The City Col...also on the doctoral faculty at the CUNY Graduate ...
(Date:12/2/2009)...LADELPHIA Cigarette smoking and alcohol consumpti...predicts the patient,s future risk of death, accor...tudy show a similar effect among those who continu...cancer survivors are counseled to quit smoking; de...cent continued to smoke even after their cancer di...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Pittsburgh G 2O Explained 3A Watch Penn State Experts on YouTube 56028 1Pittsburgh G 2O Explained 3A Watch Penn State Experts on YouTube 56028 2SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program 56025 1SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program 56025 2A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3
...ggest and most aggressive male claims the alpha ma...ut a new study from the University of Minnesota su...ore mild-mannered males can also use political beh...as gleaned from 10 years of observing dominant mal...oking at behaviors they used to compete for alpha ...
... You don,t have to get wet, or seasick, to find ou...wide. Just tune in through your computer. , This ...arth available to computers everywhere was launc...rancisco. Scientists at UC Santa Barbara are invol...te at UCSB played a key role in providing scientif...
...astating lodgepole pine stands across the West mig...f flakes containing a natural substance used in he...owding host trees, according to a team of scientis...ed study appear in the February issue of Forest E... California and Idaho, and showed how applications...
Other Biology News:Small male chimps use politics, rather than aggression, to lead the pack, U of Minnesota study says 2New version of Google Earth features California's marine protected areas 2Landscape-scale treatment promising for slowing beetle spread 2
Gey's Balanced Salt Solution (GBSS) from Sigma-Aldrich
...difications to the original formulas in efforts to... play an important role in tissue,culture. A salt ...osmotic balance in the medium and to provide the c...s valuable today as when it was first developed a ...
Ellman's Reagent from Cayman Chemical
Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
Biology Products: